Cargando…

P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea

INTRODUCTION: Mandibular advancement splint (MAS) therapy is an effective alternative to CPAP for many people with obstructive sleep apnoea (OSA) but ~50% have residual OSA. This study aimed to resolve OSA in these individuals by combining MAS with other targeted therapies based on OSA endotype char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aishah, A, Tong, B, Osman, A, Donegan, M, Pitcher, G, Kwan, B, Brown, L, Altree, T, Adam, R, Mukherjee, S, Eckert, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109059/ http://dx.doi.org/10.1093/sleepadvances/zpab014.051

Ejemplares similares

P002 CPAP therapy compliance and changes in cognitive function in patients with obstructive sleep apnoea
por: Adams, R, et al.
Publicado: (2022)

P004 Addition of an oral expiratory positive pressure valve (EPAP) to an oral appliance therapy device can resolve obstructive sleep aponea (OSA)
por: Aishah, A, et al.
Publicado: (2022)

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial
por: Altree, T, et al.
Publicado: (2021)

Non-CPAP therapy for obstructive sleep apnoea
por: Verbraecken, Johan, et al.
Publicado: (2022)

From CPAP to tailored therapy for obstructive sleep Apnoea
por: Sutherland, Kate, et al.
Publicado: (2018)

Treatment with CPAP in Elderly Patients with Obstructive Sleep Apnoea
por: Posadas, Tomas, et al.
Publicado: (2020)

O030 Reduction in fall risk markers following CPAP treatment of obstructive sleep apnoea in people over 65 years
por: Stevens, D, et al.
Publicado: (2022)

P027 Predictors of CPAP failure in severe obstructive sleep apnoea and obesity hypoventilation syndrome patients
por: Chen, K, et al.
Publicado: (2022)

P074 Night-to-night variability in obstructive sleep apnoea severity is associated with hypertension and high misdiagnosis rates
por: Lechat, B, et al.
Publicado: (2021)

P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022)

Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients
por: Drummond, Marta, et al.
Publicado: (2008)

P019 Obstructive sleep apnoea endotypes in people with multiple sclerosis
por: Carter, S, et al.
Publicado: (2021)

European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea
por: Randerath, Winfried, et al.
Publicado: (2021)

O051 Comparison of standard CPAP therapy and the RACer airway device for the treatment of obstructive sleep apnoea: A randomised clinical trial
por: Neill, A, et al.
Publicado: (2023)

Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea
por: Wang, Tsai-Yu, et al.
Publicado: (2013)

Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment
por: Seetho, Ian W, et al.
Publicado: (2015)

Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
por: Peker, Yüksel, et al.
Publicado: (2017)

O039 A Novel Approach to Quantify Breathing effort in Obstructive Sleep Apnoea
por: Nguyen, P, et al.
Publicado: (2023)

P086 The insomnia severity index is related to the respiratory arousal threshold in people with Co-Morbid Insomnia and Sleep Apnoea (COMISA)
por: Zheng, J, et al.
Publicado: (2022)

P149 The role of OSA pathophysiological traits on mandibular advancement treatment response and efficacy of a novel mandibular advancement device
por: Tong, B, et al.
Publicado: (2021)

A longitudinal study of CPAP therapy for patients with chronic cough and obstructive sleep apnoea
por: Sundar, Krishna M, et al.
Publicado: (2013)

Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
por: Muñoz-Hernandez, Rocio, et al.
Publicado: (2015)

Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment
por: Xu, Pei-Hang, et al.
Publicado: (2023)

Oral appliance treatment in moderate and severe obstructive sleep apnoea patients non‐adherent to CPAP
por: Gjerde, K., et al.
Publicado: (2015)

O026 Effect of oral appliance therapy on OSA endotypes
por: Osman, A, et al.
Publicado: (2022)

Reversal of functional changes in the brain associated with obstructive sleep apnoea following 6 months of CPAP
por: Fatouleh, Rania H., et al.
Publicado: (2015)

P124 Differences in OSA pathophysiological traits between mandibular advancement therapy responders versus non-responses and the influence of obesity
por: Tong, B, et al.
Publicado: (2022)

Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives
por: Suarez-Giron, Monique, et al.
Publicado: (2020)

Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
por: Craig, Sonya, et al.
Publicado: (2022)

O054 Genioglossus neural drive and upper airway dilation in people with obstructive sleep apnoea during wakefulness
por: Jugé, L, et al.
Publicado: (2022)

O022 Long-term cardiovascular risk in obstructive sleep apnoea: a sleep clinic cohort study
por: Shenoy, B, et al.
Publicado: (2021)

O013 The pathogenesis of obstructive sleep apnea in individuals with comorbid insomnia and obstructive sleep apnoea (COMISA)
por: Brooker, E, et al.
Publicado: (2021)

CPAP for secondary cardiovascular prevention in obstructive sleep apnoea patients: not only one moon, but many stars
por: Baillieul, Sébastien, et al.
Publicado: (2022)

P108 Obstructive Sleep Apnoea in Acute Coronary Syndrome: An Observational Study
por: Tong, B, et al.
Publicado: (2023)

P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021)

P119 Co-morbid insomnia is associated with worse health, and lower CPAP recommendation rates and nightly use in people with sleep apnoea
por: Tan, D, et al.
Publicado: (2022)

O002 A novel, optogenetics based therapy for obstructive sleep apnea
por: Knapman, F, et al.
Publicado: (2022)

O053 Cardio-metabolic Health Effects of CPAP Treatment for Sleep Apnoea during Weight Loss: A Randomised Controlled Pilot Trial.
por: Hoyos, C, et al.
Publicado: (2023)

P109 Predicting major adverse cardiovascular events using symptom subtypes of severe obstructive sleep apnoea
por: Shenoy, B, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_id61jc06kjac2931675j6j6uj5